Monoamine oxidase A (MAOA) is a mitochondrial enzyme that catalyzes the oxidative
deamination of monoamine neurotransmitters and dietary amines. Previous studies have …

Simple Summary Cell-dependent and cell-independent information drawn from the blood
stream were merged into the attractive term “liquid biopsy” and tentatively applied to most …

Background Approaches based on expression signatures of prostate cancer (PCa) have
been proposed to predict patient outcomes and response to treatments. The transcription …

Despite increasing options for treatment of castration-resistant prostate cancer, development
of drug resistance is inevitable. The glucocorticoid receptor (GR) is a prime suspect for …

In metastatic breast cancer (MBC) the molecular characterization of circulating tumor cells
(CTCs) provides a unique tool to understand metastasis-biology and therapy-resistance. We …

Abstract Background Motile Sperm Domain-Containing Protein 1 (MOSPD1) has been
implicated in breast cancer (BC) pathophysiology, but its exact role remains unclear. This …

Background The lack of distinct biomarkers for pancreatic cancer is a major cause of early-
stage detection difficulty. The pancreatic cancer patient group with high metabolic tumor …

Background Motile sperm domain containing 1 (MOSPD1) is overexpressed in colorectal,
prostate, and breast cancers, but its role in gastric cancer (GC) progression remains unclear …

Malignant peripheral nerve sheath tumor (MPNST) is a highly aggressive and recurrent soft
tissue sarcoma. It most commonly occurs secondary to neurofibromatosis type I, and it has a …

CTC analysis has already been shown to have an important impact on the prognosis,
treatment selection, and monitoring of cancer patients. In this chapter, we are focusing on …